Bio Protocol vs Solayer — how do they compare? Bio Protocol trades at Rp432.1 (market cap Rp968,72M, Rp158,58M 24h volume), while Solayer trades at Rp1,048 (market cap Rp498,16M, Rp210,25M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Solayer's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Solayer for 35 Days on average.
| BIO | LAYER | |
|---|---|---|
Market Cap | Rp968,72M | Rp498,16M |
Volume (24h) | Rp158,58M | Rp210,25M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 475,5M LAYER |
Typical Hold Time | 17 Days | 35 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
Solayer (LAYER) trades at Rp1,034.25 with a market cap of Rp491.11 million, showing bearish technical signals across moving averages and oscillators. The asset is currently testing support at S1 (Rp1,034) with resistance at R1 (Rp1,072). Hold time averages 35 days, indicating moderate holding patterns among investors. No recent protocol updates or ecosystem developments have been reported for this token.
Overall outlook remains cautious with strong bearish technical indicators suggesting potential downside pressure. Key opportunities include potential bounce from current support levels, while major risks include low liquidity, high volatility typical of small-cap cryptocurrencies, and absence of recent fundamental developments to drive price appreciation.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Solayer is the first blockchain to use specialized hardware chips to reach over 1 million transactions per second and ultra-fast network speeds. Its InfiniSVM architecture uses advanced tech like SDN, RDMA, and InfiniBand to boost performance and lower latency. This allows for near-instant blockchain applications at massive scale.
Read more on LAYER →